EUVIMEDEUVIMED entdecken
Crossref

An alternative path to oral tolerance

Carmen H Li iD, Ekaterina Kabak, Thomas Eiwegger iD

Allergy · 2023

DOI: 10.1111/all.15701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2023. Verfasst von Carmen H Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Program, Hospital for Sick Children, Research Institute, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Food Hypersensitivity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CHL and EK have nothing to disclose. TE reports to act as local PI for company sponsored trials by DBV Therapeutics, Greer Stallergens, and sub-investigator for Regeneron and ALK-Abelló. He is Co-Investigator or scientific lead in three investigator-initiated oral immunotherapy trials supported by the SickKids Food Allergy and Anaphylaxis Program and serves as an associate editor for Allergy. He/his laboratory received unconditional/in-kind contributions from Macro Array Diagnostics and an unrestricted grant from ALK-Abelló. He holds advisory board roles for ALK-Abelló, VAMED, Nutricia/Danone, and Aimmune. TE reports lecture fees from Novartis, ThermoFisher, Nutricia/Danone, Aimmune, and ALK-Abelló.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Food HypersensitivityHumansDendritic CellsImmune ToleranceAllergensAdministration, OralT-Lymphocytes, Regulatory

Stichwörter der Autor:innen

T celldendritic cellfood allergy

Substanzen

Allergens

Autor:innen und Institutionen

  • Translational Medicine Program, Hospital for Sick Children, Research Institute, Toronto, Ontario, Canada.
  • Temerty Faculty of Medicine, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Karl Landsteiner University of Health Sciences, Krems, Austria.
  • Department of Pediatric and Adolescent Medicine, University Hospital St. Pölten, St. Pölten, Austria.
  • Department of Immunology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Carmen H Li, Thomas Eiwegger

Zitieren

APA

Li, C. H., Kabak, E., & Eiwegger, T. (2023). An alternative path to oral tolerance. Allergy. https://doi.org/10.1111/all.15701

Vancouver

Li CH, Kabak E, Eiwegger T. An alternative path to oral tolerance. Allergy. 2023. doi:10.1111/all.15701

BibTeX
@article{Li2023,
  author = {Li, Carmen H and Kabak, Ekaterina and Eiwegger, Thomas},
  title = {An alternative path to oral tolerance},
  journal = {Allergy},
  year = {2023},
  doi = {10.1111/all.15701}
}
Kostenlos starten →